Rathbones Group PLC Sells 3,925 Shares of HCA Healthcare, Inc. $HCA

Rathbones Group PLC decreased its holdings in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 12.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 28,262 shares of the company’s stock after selling 3,925 shares during the quarter. Rathbones Group PLC’s holdings in HCA Healthcare were worth $12,061,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in HCA. Sunbelt Securities Inc. increased its holdings in shares of HCA Healthcare by 171.7% during the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock worth $2,954,000 after purchasing an additional 3,945 shares during the period. Darsana Capital Partners LP boosted its position in shares of HCA Healthcare by 46.7% during the 2nd quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after acquiring an additional 350,000 shares in the last quarter. Ulrich Consultants & Investment Group LLC bought a new stake in HCA Healthcare in the third quarter valued at about $2,054,000. Fund 1 Investments LLC acquired a new position in HCA Healthcare in the second quarter worth about $975,000. Finally, Bank of America Corp DE bought a new position in HCA Healthcare during the second quarter worth about $238,457,000. Institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other news, COO Jon Foster sold 21,713 shares of HCA Healthcare stock in a transaction dated Friday, November 6th. The stock was sold at an average price of $494.95, for a total transaction of $10,746,849.35. Following the transaction, the chief operating officer owned 10,000 shares in the company, valued at $4,949,500. The trade was a 68.47% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Michael Schlosser sold 1,200 shares of the stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $494.65, for a total value of $593,580.00. Following the sale, the executive vice president directly owned 1,443 shares of the company’s stock, valued at approximately $713,779.95. The trade was a 45.40% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 36,413 shares of company stock valued at $18,251,464 over the last 90 days. 1.50% of the stock is owned by company insiders.

Latest HCA Healthcare News

Here’s some of the latest news about HCA:

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Weiss Ratings raised HCA Healthcare from a “buy (b-)” rating to a “buy (b)” rating in a report on Tuesday, November 10th. Barclays upped their price target on HCA Healthcare from $387.00 to $401.00 and gave the company an “equal weight” rating in a research report on Thursday, October 29th. Oppenheimer cut their price objective on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a report on Monday, July 27th. Leerink Partners restated an “outperform” rating and issued a $492.00 target price on shares of HCA Healthcare in a research note on Friday, September 18th. Finally, Royal Bank Of Canada raised their price target on HCA Healthcare from $496.00 to $521.00 and gave the company an “outperform” rating in a report on Friday, October 30th. Sixteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $482.30.

View Our Latest Research Report on HCA

HCA Healthcare Stock Performance

NYSE HCA opened at $475.27 on Friday. The stock has a market capitalization of $99.28 billion, a P/E ratio of 15.75, a price-to-earnings-growth ratio of 1.71 and a beta of 1.11. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52. The stock has a fifty day moving average of $459.70 and a 200-day moving average of $445.75.

HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings results on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.65 by $0.57. The business had revenue of $19.85 billion for the quarter, compared to analysts’ expectations of $19.33 billion. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The firm’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter last year, the business earned $6.96 earnings per share. Equities research analysts forecast that HCA Healthcare, Inc. will post 30.14 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Tuesday, December 15th will be issued a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Tuesday, December 15th. HCA Healthcare’s dividend payout ratio is 10.34%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.

Recommended Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.